FDA Warns of Serious Lung Condition in Infants Treated with Proglycem
In a recent drug safety alert, the Food and Drug Administration (FDA) warned that a serious lung condition, pulmonary hypertension, has been reported in infants and newborns treated with Proglycem [...]